✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Sakar Healthcare Ltd.

SAKAR

Market Cap
₹657 Cr.
P/E
44.22

Sakar Healthcare Ltd.

  • Sakar Healthcare
  • Gufic Biosciences
  • Caplin Point Lab
FAQs on Sakar Healthcare Ltd. Shareprice

Sakar Healthcare has given better returns compared to its competitors.
Sakar Healthcare has grown at ~29.51% over the last 3yrs while peers have grown at a median rate of 10.7%

Yes, Sakar Healthcare is expensive.
Latest PE of Sakar Healthcare is 45.26, while 3 year average PE is 37.15.
Also latest EV/EBITDA of Sakar Healthcare is 16.62 while 3yr average is 16.52.

View FAQ's On Business
Growth Table
  • Sakar Healthcare Ltd.
  • Gufic Biosciences
  • Caplin Point Lab
Balance Sheet
  • Sakar Healthcare Ltd.
  • Gufic Biosciences
  • Caplin Point Lab
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Sakar Healthcare Ltd.
  • Gufic Biosciences
  • Caplin Point Lab
Cash Flow
  • Sakar Healthcare Ltd.
  • Gufic Biosciences
  • Caplin Point Lab
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Sakar Healthcare Ltd.
  • Gufic Biosciences
  • Caplin Point Lab
Quarterly Results
  • Sakar Healthcare Ltd.
  • Gufic Biosciences
  • Caplin Point Lab
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Sakar Healthcare Ltd. Financials

Balance sheet of Sakar Healthcare is strong.
But short term working capital might become an issue for this company.

The debt of Sakar Healthcare is decreasing.
Latest debt of Sakar Healthcare is ₹73.63 Crs as of Sep-24.
This is less than Mar-24 when it was ₹78.67 Crs.

The profit is oscillating.
The profit of Sakar Healthcare is ₹14.86 Crs for TTM, ₹11.67 Crs for Mar 2024 and ₹12.76 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Sakar Healthcare latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech